{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:07:16Z","timestamp":1787022436140,"version":"build-2736575974"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Current eligibility criteria for lung cancer (LC) screening are derived from randomized controlled trials and largely based on age and smoking history. However, the individualized benefits of screening are highly variable and may be affected by the presence of coexisting comorbid disease, including diabetes mellitus (DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study examines differences in screening outcomes for those with or without DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a secondary analysis of 53,452 high-risk subjects from the National Lung Screening Trial and compared outcomes after screening with computed tomography (CT) or chest radiography according to DM status. Models of LC mortality were derived after adjustment, and LC rate ratios (per 1,000 person-years), including 95% confidence intervals (95% CIs), were examined according to screening arm and DM status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with those without DM, subjects with DM (n\u2009=\u20095,174; 9.7%) had twofold greater baseline prevalence of cardiovascular comorbidity (P\u2009&amp;lt;\u20090.0001), twofold greater non-LC mortality (P\u2009&amp;lt;\u20090.0001), and greater LC lethality (P\u2009=\u20090.02), with more later-stage lung cancer (P\u2009=\u20090.04). We found comparable stage shift and surgical rates favoring the CT arm in both DM and non-DM subgroups, but LC mortality was higher in the CT arm for subjects with DM (2.2% vs. 2.1%), whereas for subjects without DM, it was lower (1.6% vs. 2.0%). However, the unadjusted P value for the interaction between DM status and screening arm was not significant (P\u2009=\u20090.28). In a competing-risk proportional hazards model for LC mortality adjusted for relevant risk factors, the non-DM group had a significant estimated screening benefit (hazard ratio, 0.82; 95% CI, 0.72, 0.94; P\u2009=\u20090.003), whereas the DM group did not (hazard ratio, 1.03; 95% CI, 0.71, 1.50; P\u2009=\u20090.88). However, the interaction between DM status and screening arm was again not significant (P\u2009=\u20090.27), indicating no overall screening difference according to DM status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Those reporting DM experienced more advanced LC, greater LC lethality, and greater non-LC mortality, whereas the benefits of CT-based screening remain unclear. Limitations from underpowering, lack of DM severity data, and older treatment approaches may have contributed to inconclusive results, and larger studies are warranted to better examine the effects of comorbid DM on current LC screening outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202411-1235oc","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:58:47Z","timestamp":1750431527000},"page":"1409-1418","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":2,"title":["Diabetes Mellitus and Lung Cancer Screening Outcomes in the National Lung Screening Trial"],"prefix":"10.1093","volume":"22","author":[{"given":"Robert P.","family":"Young","sequence":"first","affiliation":[{"name":"Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph C.","family":"Ward","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raewyn J.","family":"Scott","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A.","family":"Silvestri","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"2026010813103694100_bib1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","article-title":"Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial","volume":"14","author":"Aberle","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2026010813103694100_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung cancer mortality with volume CT screening in a randomised trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"key":"2026010813103694100_bib3","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","article-title":"Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy","volume":"30","author":"Pastorino","year":"2019","journal-title":"Ann Oncol"},{"key":"2026010813103694100_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jama.2021.0377","article-title":"Screening for lung cancer with low-dose computed tomography updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Jonas","year":"2021","journal-title":"JAMA"},{"key":"2026010813103694100_bib5","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.21037\/tlcr-20-890","article-title":"Lung cancer screening in Europe: where are we in 2021?","volume":"10","author":"Van Meerbeeck","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.2016.1115481","article-title":"Overtreatment in cancer\u2014is it a problem?","volume":"17","author":"Bhatt","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2026010813103694100_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.21037\/tlcr.2018.05.04","article-title":"Chronic obstructive pulmonary disease (COPD) and lung cancer screening","volume":"7","author":"Young","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/09691413221117685","article-title":"The prevalence of comorbidity in the lung cancer screening population: a systematic review and meta-analysis","volume":"30","author":"Almatrafi","year":"2023","journal-title":"J Med Screen"},{"key":"2026010813103694100_bib9","doi-asserted-by":"crossref","first-page":"855101","DOI":"10.3389\/fonc.2022.855101","article-title":"Association between diabetes risk reduction diet and lung cancer risk in 98,159 participants: results from a prospective study","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"2026010813103694100_bib10","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/djq434","article-title":"Baseline characteristics of participants in the randomised National Lung Screening Trial","volume":"102","author":"Aberle","year":"2010","journal-title":"J Nat Cancer Inst"},{"key":"2026010813103694100_bib11","doi-asserted-by":"crossref","first-page":"e225318","DOI":"10.1001\/jamanetworkopen.2022.5318","article-title":"Likelihood of lung cancer screening by poor health status and race and ethnicity in US adults, 2017 to 2020","volume":"5","author":"Rustagi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026010813103694100_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cllc.2022.03.009","article-title":"Prevalence and impact of medical comorbidities in a real-world lung cancer screening population","volume":"23","author":"Majeed","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"2026010813103694100_bib13","first-page":"100635","article-title":"The benefits and harms of lung cancer screening in individuals with comorbidities","volume":"5","author":"Kale","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"2026010813103694100_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chest.2023.08.002","article-title":"Impact of diabetes mellitus on lung cancer screening efficacy in the National Lung Screening Trial","volume":"165","author":"Young","year":"2024","journal-title":"Chest"},{"key":"2026010813103694100_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/17476348.2019.1638766","article-title":"The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic","volume":"13","author":"Young","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2026010813103694100_bib16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.chest.2020.10.070","article-title":"Incorporating baseline lung function in lung cancer screening","volume":"159","author":"Young","year":"2021","journal-title":"Chest"},{"key":"2026010813103694100_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/thorax-2022-219334","article-title":"Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters","volume":"78","author":"Young","year":"2023","journal-title":"Thorax"},{"key":"2026010813103694100_bib18","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.21037\/tlcr.2019.10.03","article-title":"Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty, and life expectancy","volume":"8","author":"Advani","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib19","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201805-0986ST","article-title":"Incorporating coexisting chronic illness into decisions about patient selection for lung cancer screening: an official American Thoracic Society research statement","volume":"198","author":"Rivera","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010813103694100_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/17476348.2023.2259800","article-title":"Should we be screening for COPD? Looking through the lens of lung cancer screening","volume":"17","author":"Young","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"2026010813103694100_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.2016.141","article-title":"Pre-existing diabetes and lung cancer prognosis","volume":"115","author":"Luo","year":"2016","journal-title":"Br J Cancer"},{"key":"2026010813103694100_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3892\/mco.2017.1224","article-title":"Survival of patients with lung cancer and diabetes mellitus","volume":"6","author":"Kurishima","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"2026010813103694100_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/1759-7714.12985","article-title":"Diabetes mellitus and survival of non-small cell lung cancer patients after surgery: a comprehensive systematic review and meta-analysis","volume":"10","author":"Deng","year":"2019","journal-title":"Thorac Cancer"},{"key":"2026010813103694100_bib24","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1002\/cncr.28326","article-title":"The National Lung Screening Trial: results stratified by demographics, smoking history and lung cancer histology","volume":"119","author":"Pinsky","year":"2013","journal-title":"Cancer"},{"key":"2026010813103694100_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/aje\/kws156","article-title":"Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study","volume":"176","author":"Schneider","year":"2012","journal-title":"Am J Epidemiol"},{"key":"2026010813103694100_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the sub-distribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statist Assoc"},{"key":"2026010813103694100_bib27","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.21037\/tlcr-22-63","article-title":"Lung function impairment in the German Lung Cancer Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumour histology and all-cause mortality","volume":"11","author":"Kaaks","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib28","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.21037\/tlcr-22-634","article-title":"Lung function impairment in lung cancer screening: discordance between risk and screening outcomes when looking through a PRISm","volume":"11","author":"Young","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M23-0653","article-title":"Rates of downstream procedures and complications associated with lung cancer screening in routine clinical practice: a retrospective cohort study","volume":"177","author":"Rendle","year":"2024","journal-title":"Ann Intern Med"},{"key":"2026010813103694100_bib30","first-page":"A4953","article-title":"Elevated BMI predicts poor lung cancer screening outcomes independent of diabetes mellitus in a National Lung Screening Trial subgroup (n=18,463) [abstract]","volume":"209","author":"Young","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010813103694100_bib31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2022.1820","article-title":"Collider bias","volume":"327","author":"Holmberg","year":"2022","journal-title":"JAMA"},{"key":"2026010813103694100_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00595-017-1612-9","article-title":"The pre-operative HbA1c level is an independent prognostic factor for the post-operative survival after resection of non-small lung cancer in elderly patients","volume":"48","author":"Motoishi","year":"2018","journal-title":"Surg Today"},{"key":"2026010813103694100_bib33","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1111\/1759-7714.14174","article-title":"Haemoglobin A1c level is a prognostic factor for loco-regional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy","volume":"12","author":"Kong","year":"2021","journal-title":"Thorac Cancer"},{"key":"2026010813103694100_bib34","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.3390\/jcm11195933","article-title":"Association of glycosylated haemoglobin level and cancer-related mortality in patients without diabetes","volume":"11","author":"Yoo","year":"2022","journal-title":"J Clin Med"},{"key":"2026010813103694100_bib35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"2026010813103694100_bib36","doi-asserted-by":"crossref","first-page":"615375","DOI":"10.3389\/fonc.2020.615375","article-title":"Obesity, type 2 diabetes, and cancer risk","volume":"10","author":"Scully","year":"2020","journal-title":"Front Oncol"},{"key":"2026010813103694100_bib37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/ol.2014.2302","article-title":"Clinical significance of the \u2018not otherwise specified\u2019 subtype in candidates for resectable non-small cell lung cancer","volume":"8","author":"Tane","year":"2014","journal-title":"Oncol Lett"},{"key":"2026010813103694100_bib38","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/JTO.0000000000000271","article-title":"Impact of non-small-cell lung cancer\u2013not otherwise specified immunotyping on treatment outcome","volume":"9","author":"Righi","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2026010813103694100_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1095-0397(99)00029-1","article-title":"Diabetes decreases FDG accumulation in primary lung cancer","volume":"2","author":"Torizuka","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"2026010813103694100_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1513\/AnnalsATS.202408-863OC","article-title":"Why women appear to have better outcomes when undergoing screening for lung cancer","volume":"22","author":"Silvestri","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"2026010813103694100_bib41","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jtho.2019.05.031","article-title":"Body mass index (BMI), BMI change, and overall survival in patients with SCLC and NSLC: a pooled analysis of the International Lung Cancer Consortium","volume":"14","author":"Shepshelovich","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2026010813103694100_bib42","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.21037\/jtd-22-1835","article-title":"Obesity and lung cancer\u2014a narrative review","volume":"15","author":"Vedire","year":"2023","journal-title":"J Thorac Dis"},{"key":"2026010813103694100_bib43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/cancers14061440","article-title":"Exploring the impact of the obesity paradox on lung cancer and other malignancies","volume":"14","author":"Nitsche","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026010813103694100_bib44","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/cancers13184574","article-title":"The reality of lung cancer paradox: the impact of body mass index on long-term survival of resected lung cancer. A French nationwide analysis from the Epithor database","volume":"13","author":"Alifano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026010813103694100_bib45","doi-asserted-by":"crossref","first-page":"e000369","DOI":"10.1136\/bmjdrc-2016-000369","article-title":"Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study","volume":"5","author":"Badrick","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026010813103694100_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.chest.2019.06.016","article-title":"Patient-level trajectories and outcomes after low-dose CT screening in the National Lung Screening Trial","volume":"156","author":"Iaccarino","year":"2019","journal-title":"Chest"},{"key":"2026010813103694100_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cllc.2022.03.012","article-title":"Impact of comorbidities on lung cancer screening evaluation","volume":"23","author":"Robinson","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"2026010813103694100_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12931-019-1209-5","article-title":"BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials","volume":"20","author":"Sun","year":"2019","journal-title":"Respir Res"},{"key":"2026010813103694100_bib49","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/joim.12949","article-title":"The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality","volume":"286","author":"Park","year":"2019","journal-title":"J Intern Med"},{"key":"2026010813103694100_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.21037\/tlcr.2018.06.03","article-title":"Selecting lung cancer screenees using risk prediction models\u2014where do we go from here","volume":"7","author":"Tammemagi","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2026010813103694100_bib51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/EDE.0000000000000493","article-title":"Collider bias is only a partial explanation for the obesity paradox","volume":"27","author":"Sperrin","year":"2016","journal-title":"Epidemiology"},{"key":"2026010813103694100_bib52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12885-015-2012-4","article-title":"Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer","volume":"15","author":"Imai","year":"2015","journal-title":"BMC Cancer"},{"key":"2026010813103694100_bib53","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/jnci\/djaa170","article-title":"State variation in low-dose computed tomography scanning for lung cancer screening in the United States","volume":"113","author":"Fedewa","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"2026010813103694100_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4104\/pcrj.2012.00027","article-title":"Spirometry-defined restrictive ventilatory defect: population variability and individual determinants","volume":"21","author":"Soriano","year":"2012","journal-title":"Prim Care Respir J"},{"key":"2026010813103694100_bib55","doi-asserted-by":"crossref","first-page":"100100","DOI":"10.1016\/j.metrad.2024.100100","article-title":"Thoracic CT imaging in obesity: technical challenges, imaging findings and future outlook","volume":"2","author":"Suwathep","year":"2024","journal-title":"Meta-Radiology"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/9\/1409\/66284611\/annalsats_22_9_1409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/9\/1409\/66284611\/annalsats_22_9_1409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:15:46Z","timestamp":1767896146000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/22\/9\/1409\/8287424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,1]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202411-1235oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"2024-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}